Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) plus cobimetinib (C): Updated results from the phase III IMspire150 study

K. Lewis, C. Robert, R. Ramella Munhoz, G. Liszkay,L. De la Cruz Merino, J. Olah, P. Queirolo, J. Mackiewicz, H. Li, Q. Zhu, C. Hertig, N. Paranthaman,E. F. McKenna, R. Gutzmer,G. McArthur,P. A. Ascierto

ANNALS OF ONCOLOGY(2022)

引用 1|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要